Physician profile
Jonathan C Gabel
NPI 1245249937
$3,424.28
in general payments reported to CMS, 2019-2025
7 companies · $851 in 2025
The $851 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $191 · 2021: $24.84 · 2022: $866 · 2023: $569 · 2024: $749 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,821 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,820.97 |
| Travel and Lodging | $348.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $921.79 | 2023-2024 | |
| Stryker Corporation | $787.79 | 2019-2025 | Mako |
| Depuy Synthes Sales INC. | $580.00 | 2022 | |
| Smith+Nephew, INC. | $499.74 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Fast-Fix, Firstpass |
| Zimmer Biomet Holdings, INC. | $491.96 | 2023-2025 | |
| Medical Device Business Services, INC. | $118.16 | 2022-2024 | Inhance |
| Pacira Pharmaceuticals Incorporated | $24.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gabel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.